These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 29414258)

  • 1. Common Cardiovascular Complications of Cancer Therapy: Epidemiology, Risk Prediction, and Prevention.
    Narayan V; Ky B
    Annu Rev Med; 2018 Jan; 69():97-111. PubMed ID: 29414258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardio-oncology, the myth of Sisyphus, and cardiovascular disease in breast cancer survivors.
    Mavrogeni SI; Sfendouraki E; Markousis-Mavrogenis G; Rigopoulos A; Noutsias M; Kolovou G; Angeli C; Tousoulis D
    Heart Fail Rev; 2019 Nov; 24(6):977-987. PubMed ID: 31134427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies to Prevent Cardiotoxicity.
    Graffagnino J; Kondapalli L; Arora G; Hawi R; Lenneman CG
    Curr Treat Options Oncol; 2020 Apr; 21(4):32. PubMed ID: 32270293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits of antihypertensive medications for anthracycline- and trastuzumab-induced cardiotoxicity in patients with breast cancer: Insights from recent clinical trials.
    Rygiel K
    Indian J Pharmacol; 2016; 48(5):490-497. PubMed ID: 27721532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiotoxicity of Contemporary Breast Cancer Treatments.
    Lee Chuy K; Yu AF
    Curr Treat Options Oncol; 2019 May; 20(6):51. PubMed ID: 31073788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cardiovascular complications of cancers and anti-cancer therapy].
    Vyskočil J; Petráková K; Jelínek P; Furdek M
    Vnitr Lek; 2017; 63(3):200-209. PubMed ID: 28379023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiotoxicity of anticancer therapies. Towards the implementation of cardio-oncology units].
    Hameau R; Gabrielli L; Garrido M; Guzmán AM; Retamal I; Vacarezza MJ; Greig D; Ocqueteau M; Sánchez C; Pizarro M; Corvalán A; Lavandero S; Castro PF; Martínez G
    Rev Med Chil; 2018 Jan; 146(1):68-77. PubMed ID: 29806680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular diseases in survivors of childhood cancer.
    Bansal N; Blanco JG; Sharma UC; Pokharel S; Shisler S; Lipshultz SE
    Cancer Metastasis Rev; 2020 Mar; 39(1):55-68. PubMed ID: 32026204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac Complications of Cancer Therapy: Pathophysiology, Identification, Prevention, Treatment, and Future Directions.
    Jain D; Russell RR; Schwartz RG; Panjrath GS; Aronow W
    Curr Cardiol Rep; 2017 May; 19(5):36. PubMed ID: 28374177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardio-oncology: Understanding cardiotoxicity to guide patient focused imaging.
    Russell R
    J Nucl Cardiol; 2018 Dec; 25(6):2159-2167. PubMed ID: 30443750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiotoxicity of Targeted Cancer Drugs: Concerns, "The Cart Before the Horse," and Lessons from Trastuzumab.
    Menna P; Minotti G; Salvatorelli E
    Curr Cardiol Rep; 2019 Mar; 21(5):33. PubMed ID: 30887161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excess heart age in young breast cancer survivors over 2-year follow-up.
    Vo JB; Kenzik KM; Landier W; Raju D; Kirklin JK; Meneses K
    Cancer Causes Control; 2021 Jun; 32(6):617-626. PubMed ID: 33763790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic cardiovascular toxicity in the older oncology patient population.
    Findlay SG; Gill JH; Plummer R; DeSantis C; Plummer C
    J Geriatr Oncol; 2019 Sep; 10(5):685-689. PubMed ID: 30733001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Growing Impact of Cardiovascular Oncology: Epidemiology and Pathophysiology.
    Tufano A; Coppola A; Galderisi M
    Semin Thromb Hemost; 2021 Nov; 47(8):899-906. PubMed ID: 34255338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management.
    Curigliano G; Cardinale D; Dent S; Criscitiello C; Aseyev O; Lenihan D; Cipolla CM
    CA Cancer J Clin; 2016 Jul; 66(4):309-25. PubMed ID: 26919165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiotoxicity among adult survivors suffered from childhood malignancies.
    Petropoulos AC; Moschovi M
    Hell J Nucl Med; 2019; 22 Suppl 2():34-40. PubMed ID: 31802042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiotoxicity: anthracyclines and long term cancer survivors.
    Patanè S
    Int J Cardiol; 2014 Oct; 176(3):1326-8. PubMed ID: 25129289
    [No Abstract]   [Full Text] [Related]  

  • 18. Decision Science Can Inform Clinical Trade-Offs Regarding Cardiotoxic Cancer Treatments.
    Gillman AS; Vo JB; Nohria A; Ferrer RA
    JNCI Cancer Spectr; 2021 Aug; 5(4):. PubMed ID: 34350379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardio-oncology: cardiovascular complications of cancer therapy.
    Henning RJ; Harbison RD
    Future Cardiol; 2017 Jul; 13(4):379-396. PubMed ID: 28660778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioprotective Strategies to Prevent Cancer Treatment-Related Cardiovascular Toxicity: a Review.
    Upshaw JN
    Curr Oncol Rep; 2020 Jun; 22(7):72. PubMed ID: 32564220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.